AZTA vs. CHX, WHD, WFRD, HAYW, ATS, HSAI, EPAC, SEI, FLOC, and DNOW
Should you be buying Azenta stock or one of its competitors? The main competitors of Azenta include ChampionX (CHX), Cactus (WHD), Weatherford International (WFRD), Hayward (HAYW), ATS (ATS), Hesai Group (HSAI), Enerpac Tool Group (EPAC), Solaris Energy Infrastructure (SEI), Flowco (FLOC), and DNOW (DNOW). These companies are all part of the "machinery" industry.
Azenta vs. Its Competitors
Azenta (NASDAQ:AZTA) and ChampionX (NASDAQ:CHX) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, profitability, media sentiment, earnings, community ranking, risk, institutional ownership and valuation.
ChampionX has higher revenue and earnings than Azenta. Azenta is trading at a lower price-to-earnings ratio than ChampionX, indicating that it is currently the more affordable of the two stocks.
In the previous week, ChampionX had 2 more articles in the media than Azenta. MarketBeat recorded 3 mentions for ChampionX and 1 mentions for Azenta. Azenta's average media sentiment score of 1.87 beat ChampionX's score of 1.85 indicating that Azenta is being referred to more favorably in the media.
Azenta pays an annual dividend of $0.10 per share and has a dividend yield of 0.3%. ChampionX pays an annual dividend of $0.38 per share and has a dividend yield of 1.5%. Azenta pays out -7.2% of its earnings in the form of a dividend. ChampionX pays out 25.2% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. ChampionX has increased its dividend for 2 consecutive years. ChampionX is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.
Azenta has a beta of 1.62, suggesting that its share price is 62% more volatile than the S&P 500. Comparatively, ChampionX has a beta of 1.51, suggesting that its share price is 51% more volatile than the S&P 500.
Azenta currently has a consensus price target of $50.67, indicating a potential upside of 65.20%. ChampionX has a consensus price target of $37.67, indicating a potential upside of 44.73%. Given Azenta's higher probable upside, research analysts plainly believe Azenta is more favorable than ChampionX.
ChampionX received 2 more outperform votes than Azenta when rated by MarketBeat users. Likewise, 54.00% of users gave ChampionX an outperform vote while only 43.10% of users gave Azenta an outperform vote.
99.1% of Azenta shares are owned by institutional investors. Comparatively, 99.0% of ChampionX shares are owned by institutional investors. 10.6% of Azenta shares are owned by company insiders. Comparatively, 1.5% of ChampionX shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
ChampionX has a net margin of 8.81% compared to Azenta's net margin of -24.91%. ChampionX's return on equity of 19.84% beat Azenta's return on equity.
Summary
ChampionX beats Azenta on 13 of the 20 factors compared between the two stocks.
Get Azenta News Delivered to You Automatically
Sign up to receive the latest news and ratings for AZTA and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding AZTA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
This page (NASDAQ:AZTA) was last updated on 6/11/2025 by MarketBeat.com Staff
